Tag archive for ‘Nasdaq IPO’
Shiri Habib-Valdhorn On Monday, December 15th, 2014

Outbrain readies for Nasdaq IPO with senior appointment

– The Israeli content recommendation company has appointed former Check Point exec Ronen Koehler as head of staff. Outbrain is bolstering its management structure ahead of its planned IPO on Wall Street. More...

Nadav Neuman On Sunday, November 30th, 2014

Outbrain files for Nasdaq IPO at $1 billion company value – report

– The Israeli content recommendation company filed confidentially, the “Wall Street Journal” reports. Outbrain Inc. has filed confidentially with the US Securities and Exchange Commission More...

Gali Weinreb On Thursday, November 13th, 2014

Drug developer NeuroDerm to begin Nasdaq IPO

–  The Israeli Parkinson’s disease treatment developer is seeking $58-72 million at a company value of $290 million. –   Rehovot-based NeuroDerm, which has developed a transdermal drug More...

Gali Weinreb On Thursday, October 2nd, 2014

VBL Therapeutics raises $40 million in revived Nasdaq IPO

– After the fiasco of the failed IPO in August, the drug development company scaled down the offering. VBL Therapeutics has raised $40 million at a company value of $120 million in a revived IPO on Nasdaq. More...

Gil Tanenbaum On Sunday, September 28th, 2014

CyberArk Software nearly doubles after Nasdaq IPO

– The Israel based cyber security company has a market cap of $881 million. –   Israeli cyber security firm CyberArk has made a huge impact with its NASDAQ IPO, which was held on the eve of More...

Gali Weinreb On Thursday, September 4th, 2014

Foamix sets terms for $71 million Nasdaq IPO

– Foamix integrates its foam technology with existing drugs used to treat skin diseases like acne. – Foamix, which develops foam-based drugs, today revised its prospectus for its upcoming IPO More...

ReWalk Robotics
Tali Tsipori On Wednesday, August 27th, 2014

ReWalk Robotics sets terms for $50 million Nasdaq IPO

– The company plans the offering in the second week of September. – – ReWalk Robotics has set terms for its Nasdaq IPO. The Israel-based company recently changed its name from Argo Medical More...

Jewish Business News On Thursday, July 31st, 2014

Israeli Macrocure raises $54 million in Nasdaq IPO

– The advanced cell therapy for chronic wound therapy company pricing of the shares at $10 was well below the $13-15 range that the company had planned. Regenerative medicine developer Macrocure Ltd. has More...

Globes On Thursday, July 31st, 2014

VBL Therapeutics prices Nasdaq IPO

– The clinical stage biotech company is selling 5.4 million ordinary shares at $12 each. Clinical-stage biotech company VBL Therapeutics has announced the pricing of its Nasdaq IPO. The company is selling More...

Gil Tanenbaum On Wednesday, June 25th, 2014

MacroCure Is The latest Israeli Biotech Firm to Go public In The US

– Startup nation continues to shine in the field of biotechnology while shunning Israeli exchanges. – – Israeli biotech firm MacroCure has announced plans to hold an initial public offering More...

Wordpress site Developed by Fixing WordPress Problems